| Dr Krupesh Bhakta, DO | |
|
2020 Wellness Way Ste 300, Las Vegas, NV 89106-4145 | |
| (702) 432-2233 | |
| (702) 800-5456 |
| Full Name | Dr Krupesh Bhakta |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 7 Years |
| Location | 2020 Wellness Way Ste 300, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114452687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0600X | Psychiatry & Neurology - Clinical Neurophysiology | DO3126 (Nevada) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | DO3126 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summerlin Hospital Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Janda Mahajan And Balsiger Pllc | 7315257797 | 23 |
News Archive
With pollution levels described by the government as ‘very high' or ‘high' this week in eight regions across the UK, we chat to Dr Anjali Mahto, Consultant Dermatologist & British Skin Foundation Spokesperson to see what measures you can take at home to protect your skin.
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, announced today that it expects to generate record revenue and positive cash flow from operating activities during its fiscal quarter ended March 31, 2010 due to the successful launch of several large-scale sales campaigns by its partners.
Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
› Verified 2 days ago
| Entity Name | Janda Mahajan & Balsiger Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457731242 PECOS PAC ID: 7315257797 Enrollment ID: O20151116000744 |
News Archive
With pollution levels described by the government as ‘very high' or ‘high' this week in eight regions across the UK, we chat to Dr Anjali Mahto, Consultant Dermatologist & British Skin Foundation Spokesperson to see what measures you can take at home to protect your skin.
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, announced today that it expects to generate record revenue and positive cash flow from operating activities during its fiscal quarter ended March 31, 2010 due to the successful launch of several large-scale sales campaigns by its partners.
Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Krupesh Bhakta, DO 1930 Village Center Cir Ste 3-717, Las Vegas, NV 89134-6299 Ph: (702) 432-2233 | Dr Krupesh Bhakta, DO 2020 Wellness Way Ste 300, Las Vegas, NV 89106-4145 Ph: (702) 432-2233 |
News Archive
With pollution levels described by the government as ‘very high' or ‘high' this week in eight regions across the UK, we chat to Dr Anjali Mahto, Consultant Dermatologist & British Skin Foundation Spokesperson to see what measures you can take at home to protect your skin.
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
National Health Partners, Inc., a leading provider of unique discount healthcare membership programs, announced today that it expects to generate record revenue and positive cash flow from operating activities during its fiscal quarter ended March 31, 2010 due to the successful launch of several large-scale sales campaigns by its partners.
Pfizer Inc. today announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of attention deficit hyperactivity disorder (ADHD).
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
› Verified 2 days ago
Dr. Ejine Okoroafor, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5440 W Sahara Ave, Suite 202, Las Vegas, NV 89146 Phone: 914-426-7774 | |
Dr. Garet Jefferson Zaugg, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 300, Las Vegas, NV 89106 Phone: 702-432-2233 Fax: 702-800-5456 | |
Dr. Muhammed A Hyder, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2465 E Twain Ave, Las Vegas, NV 89121 Phone: 702-789-6201 Fax: 304-522-0686 | |
Dr. Krista Linn Pinard, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3016 W Charleston Blvd Ste 150, Las Vegas, NV 89102 Phone: 702-790-2701 | |
Gobinder S. Chopra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6410 Medical Center St Ste A100, Las Vegas, NV 89148 Phone: 702-796-8500 Fax: 702-796-8502 | |
Eden Santiago Lee, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3014 W Charleston Blvd Ste 130, Las Vegas, NV 89102 Phone: 702-671-6475 Fax: 702-671-6440 | |
John Reitano, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 501 S Rancho Dr, Ste I62, Las Vegas, NV 89106 Phone: 702-897-7250 Fax: 702-706-4838 |